41110611000001100: Tezepelumab (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament\Monoclonal antibody\Tezepelumab

\Substance categorized by structure\Chemical\Chemical categorized by structure\...

\Nitrogen and/or nitrogen compound\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide\Polypeptide\Protein\Antibody\Monoclonal antibody\Tezepelumab

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative\Substituted amide\Polypeptide\Protein\Antibody\Monoclonal antibody\Tezepelumab

\Biological substance\Immunologic substance\Antibody\Monoclonal antibody\Tezepelumab
\Biological substance\Polypeptide\Protein\Antibody\Monoclonal antibody\Tezepelumab

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 26-Oct 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

2464751000001117 Tezepelumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2464761000001119 Tezepelumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Tezepelumab	Is a	Monoclonal antibody	true	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Tezepelumab 210mg/1.91ml solution for injection pre-filled syringes	Has specific active ingredient	True	Tezepelumab	Inferred relationship	Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd)	Has specific active ingredient	True	Tezepelumab	Inferred relationship	Existential restriction modifier
Tezepelumab 210mg/1.91ml solution for injection pre-filled syringes 1 pre-filled disposable injection	Has specific active ingredient	True	Tezepelumab	Inferred relationship	Existential restriction modifier
Tezspire 210mg/1.91ml solution for injection pre-filled syringes (AstraZeneca UK Ltd) 1 pre-filled disposable injection	Has specific active ingredient	True	Tezepelumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets